For the first time in 10 years, the American Heart Association has updated the model to predict someone’s risk of developing heart disease.
Nearly everyone can lower their blood pressure, even people currently on blood pressure-reducing drugs, by lowering their sodium intake, according to a new study published in JAMA.
A new Northwestern Medicine study has found obesity before pregnancy is the root cause of future cardiovascular disease, rather than pregnancy complications.
A novel cellular pathway regulates DNA damage and structural changes in cardiomyocytes which contributes to the development of cardiac hypertrophy according to a Northwestern Medicine study published in Circulation.
The antidiabetic and weight loss drug semaglutide, sold under the brand names Ozempic and Wegovy, can also help patients with heart failure and obesity lose weight while also improving symptoms and increasing exercise capacity, according to a clinical trial published in the New England Journal of Medicine.
Investigators have identified more than 60 previously unknown genetic variants associated with resting heart rate that may also contribute to increased risk of cardiovascular disease, according to findings published in Nature Communications.
The Coronary Artery Risk Development in Young Adults (CARDIA) study has received a 10-year $11 million grant renewal from the National Heart, Lung, and Blood Institute at the National Institutes of Health.
Black residents living in highly segregated neighborhoods have significantly shortened life expectancies, according to a new Northwestern Medicine study.
Despite having risk factors for heart disease, only 60 percent of women reported receiving counseling on optimizing their heart health at their six-week postpartum visits, according to a new Northwestern study.
A newly developed wireless implant monitors and treats heart disease, then harmlessly dissolves inside the body, bypassing the need for extraction.